JP2024539090A5 - - Google Patents
Info
- Publication number
- JP2024539090A5 JP2024539090A5 JP2024523404A JP2024523404A JP2024539090A5 JP 2024539090 A5 JP2024539090 A5 JP 2024539090A5 JP 2024523404 A JP2024523404 A JP 2024523404A JP 2024523404 A JP2024523404 A JP 2024523404A JP 2024539090 A5 JP2024539090 A5 JP 2024539090A5
- Authority
- JP
- Japan
- Prior art keywords
- trimetazidine
- acid
- pharmaceutical composition
- composition according
- trimetazidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306465.2 | 2021-10-20 | ||
| EP21306465 | 2021-10-20 | ||
| PCT/EP2022/079054 WO2023066971A1 (en) | 2021-10-20 | 2022-10-19 | Novel trimetazidine salts |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539090A JP2024539090A (ja) | 2024-10-28 |
| JP2024539090A5 true JP2024539090A5 (enExample) | 2025-11-06 |
Family
ID=78592764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523404A Pending JP2024539090A (ja) | 2021-10-20 | 2022-10-19 | 新規トリメタジジン塩 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20250250245A1 (enExample) |
| EP (1) | EP4419510B1 (enExample) |
| JP (1) | JP2024539090A (enExample) |
| KR (1) | KR20240093576A (enExample) |
| CN (1) | CN118076591A (enExample) |
| AR (1) | AR127403A1 (enExample) |
| AU (1) | AU2022369026A1 (enExample) |
| CR (1) | CR20240157A (enExample) |
| DK (1) | DK4419510T3 (enExample) |
| ES (1) | ES3057370T3 (enExample) |
| HR (1) | HRP20251413T1 (enExample) |
| IL (1) | IL311916A (enExample) |
| LT (1) | LT4419510T (enExample) |
| MA (1) | MA66951B1 (enExample) |
| MX (1) | MX2024004714A (enExample) |
| PL (1) | PL4419510T3 (enExample) |
| PT (1) | PT4419510T (enExample) |
| RS (1) | RS67449B1 (enExample) |
| SI (1) | SI4419510T1 (enExample) |
| WO (1) | WO2023066971A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025106477A1 (en) * | 2023-11-14 | 2025-05-22 | Samsara Therapeutics Inc. | Novel autophagy inducing compounds and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104138376A (zh) * | 2013-05-06 | 2014-11-12 | 常州高新技术产业开发区三维工业技术研究所有限公司 | 一种提高缺氧耐受力的缓释剂 |
| FR3027803B1 (fr) | 2014-11-05 | 2018-02-09 | Les Laboratoires Servier | Composition pharmaceutique comprenant un betabloquant et un inhibiteur de l'enzyme de conversion |
| CN105287564A (zh) * | 2015-09-06 | 2016-02-03 | 余祖江 | 一种防治肝病的西药复合物及其用途 |
| CN110183398B (zh) | 2019-05-14 | 2021-06-29 | 中南民族大学 | 一种曲美他嗪草酸盐及其制备方法和应用 |
| CN110105307B (zh) | 2019-05-14 | 2021-06-01 | 中南民族大学 | 一种曲美他嗪草酸盐及其制备方法和应用 |
| CN110054599B (zh) * | 2019-05-14 | 2021-05-07 | 中南民族大学 | 一种曲美他嗪草酸盐及其制备方法和应用 |
| CN112043691A (zh) * | 2019-06-06 | 2020-12-08 | 常州高新技术产业开发区三维工业技术研究所有限公司 | 一种药物组合物及其用途 |
-
2022
- 2022-10-19 RS RS20251183A patent/RS67449B1/sr unknown
- 2022-10-19 MX MX2024004714A patent/MX2024004714A/es unknown
- 2022-10-19 CR CR20240157A patent/CR20240157A/es unknown
- 2022-10-19 LT LTEPPCT/EP2022/079054T patent/LT4419510T/lt unknown
- 2022-10-19 US US18/702,363 patent/US20250250245A1/en active Pending
- 2022-10-19 AR ARP220102840A patent/AR127403A1/es unknown
- 2022-10-19 EP EP22808665.8A patent/EP4419510B1/en active Active
- 2022-10-19 IL IL311916A patent/IL311916A/en unknown
- 2022-10-19 PL PL22808665.8T patent/PL4419510T3/pl unknown
- 2022-10-19 AU AU2022369026A patent/AU2022369026A1/en active Pending
- 2022-10-19 ES ES22808665T patent/ES3057370T3/es active Active
- 2022-10-19 SI SI202230206T patent/SI4419510T1/sl unknown
- 2022-10-19 PT PT228086658T patent/PT4419510T/pt unknown
- 2022-10-19 DK DK22808665.8T patent/DK4419510T3/da active
- 2022-10-19 HR HRP20251413TT patent/HRP20251413T1/hr unknown
- 2022-10-19 WO PCT/EP2022/079054 patent/WO2023066971A1/en not_active Ceased
- 2022-10-19 MA MA66951A patent/MA66951B1/fr unknown
- 2022-10-19 JP JP2024523404A patent/JP2024539090A/ja active Pending
- 2022-10-19 CN CN202280068113.8A patent/CN118076591A/zh active Pending
- 2022-10-19 KR KR1020247015968A patent/KR20240093576A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240300969A1 (en) | Prodrugs of Fumarates and Their Use in Treating Various Diseases | |
| JP5292404B2 (ja) | Ｎ，ｎ−ジメチルイミドジカルボンイミド酸ジアミドのジカルボン酸塩、その製造方法、及びその薬剤学的組成物 | |
| JP2005516009A (ja) | 重水素化された置換ピラゾリル−ベンゼンスルホンアミド並びにこれを含有する医薬品 | |
| KR101212908B1 (ko) | 무스카린 수용체 안타고니스트의 안정한 수화물 | |
| JP2014523886A (ja) | 置換シンナムアミド誘導体、その製造方法及び使用 | |
| TW200918506A (en) | Indane-amine derivatives, their preparation and use as medicaments | |
| WO2008104590A2 (en) | Novel dosage form | |
| CN113831338A (zh) | 一种组蛋白去乙酰化酶抑制剂及其制备方法和应用 | |
| US4100170A (en) | Anorectic adamantane derivatives and method of using the same | |
| JP2026504208A (ja) | ベンゾイソチアゾール化合物、その医薬組成物および用途 | |
| JPS5929190B2 (ja) | スルホンアミド化合物 | |
| KR102003847B1 (ko) | 염산 욘커나필(yonkenafil)의 결정다형 및 그 제조 방법, 조성물과 용도 | |
| US3982020A (en) | Substituted benzylidene hydrazines for treating hyperglycemia, obesity and inflammation | |
| JP5486008B2 (ja) | １‐ブチル‐２‐ヒドロキシアラルキルピペラジン誘導体およびその抗鬱剤としての使用 | |
| HRP20251413T1 (hr) | Nove soli trimetazidina | |
| US20110189280A1 (en) | Dosage form comprising 1-isopropyl-4-hexahydro-1h-1,4-diazepine or a salt thereof | |
| CN104496994A (zh) | 一种炔类杂芳基化合物的新晶型 | |
| US10941153B2 (en) | Substituted phenethylamine derivatives | |
| US10301256B2 (en) | Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases | |
| CN110229081A (zh) | 2,4-二硝基苯腙衍生物及其制备方法与应用 | |
| CN111100074B (zh) | 哒嗪腙衍生物及其制备方法与应用 | |
| RU2023129313A (ru) | Дейтерированные гетероциклические кетоновые соединения и их применение | |
| US4004032A (en) | Pharmaceutical compositions containing a 1-(3-trifluoromethyl-4'-chloro-phenyl)-2-(carboxylic acylakyl-amino) propane and method of use | |
| US3644648A (en) | Antiadrenal compositions comprising triphenylpropyl amines | |
| CA1040647A (en) | Intermediates for novel 3-amino-prop-1-enes |